Art

J-GLOBAL ID：201702288893114532   Reference number：17A1214961

Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape

癌免疫療法:急速に進化する臨床景観における機会と挑戦【Powered by NICT】

Author (9)： Emens Leisha A. (Johns Hopkins University School of Medicine, Department of Oncology, Graduate Program in Pathobiology, Baltimore, MD 21287, USA) ,  Ascierto Paolo A. (Istituto Nazionale Tumori Fondazione G. Pascale, Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Napoli, Italy) ,  Darcy Phillip K. (Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia) ,  Darcy Phillip K. (Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville 3010, Australia) ,  Demaria Sandra (Weill Cornell Medical College, Department of Radiation Oncology, New York, NY 10065, USA) ,  Eggermont Alexander M.M. (Cancer Institute Gustave-Roussy, 114 Rue Edouard Vaillant, Villejuif/Paris-Sud 94800, France) ,  Redmond William L. (Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, OR 97213, USA) ,  Seliger Barbara (Martin Luther University, Institute for Medical Immunology, Magdeburger Str. 2, 06112 Halle, Germany) ,  Marincola Francesco M. (Research Branch, Sidra Medical and Research Centre, Doha, Qatar)
Material： European Journal of Cancer  (Eur J Cancer)
Volume： 81  Page： 116-129  Publication year： 2017 
JST Material Number： A0802C  ISSN： 0959-8049  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Abstract/Point： Cancer immunotherapy is now es...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1214961&from=J-GLOBAL&jstjournalNo=A0802C") }}

Thesaurus term： biomarker ,  tumor ,  therapy ,  adjuvant ,  *high speed ,  cytotoxicity ,  patient ,  Decision Making ,  *Immunotherapy ,  Chronic Disease ,  Immune System
Semi thesaurus term： 癌治療 ,  生存期間 ,  *癌免疫療法 , 【Automatic Indexing@JST】

Author keywords (6)： Tumour immunity ,  Cancer immunotherapy ,  Immune checkpoint blockade ,  Cytotoxic T lymphocyte antigen-4 (CTLA-4) ,  Programmed death-1 (PD-1) ,  Programmed death ligand-1 (PD-L1)

JST classification (2)： Tumor immunity  (ED03040A) ,  Experimental treatment for tumors  (GE02040Y)

Terms in the title (5)： 癌免疫療法 ,  進化 ,  臨床 ,  景観 ,  機会